Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Moolec Science SA (MLEC)

Compare
0.5810
-0.0510
(-8.07%)
At close: April 3 at 4:00:00 PM EDT
0.6530
+0.07
+(12.39%)
After hours: April 3 at 4:31:07 PM EDT
Loading Chart for MLEC
  • Previous Close 0.6320
  • Open 0.6530
  • Bid 0.4060 x 200
  • Ask 0.8489 x 200
  • Day's Range 0.5810 - 0.6530
  • 52 Week Range 0.5300 - 3.2500
  • Volume 756
  • Avg. Volume 18,819
  • Market Cap (intraday) 23.242M
  • Beta (5Y Monthly) -0.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2000
  • Earnings Date Apr 4, 2025 - Apr 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.00

Moolec Science SA, a science-based food ingredient company, focuses on developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology. It develops textured soy proteins, safflower oil, meat replacement products, food ingredients, and nutritional supplements. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg, Luxembourg.

moolecscience.com

52

Full Time Employees

June 30

Fiscal Year Ends

Recent News: MLEC

View More

Performance Overview: MLEC

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MLEC
27.38%
S&P 500 (^GSPC)
8.25%

1-Year Return

MLEC
56.18%
S&P 500 (^GSPC)
3.55%

3-Year Return

MLEC
94.15%
S&P 500 (^GSPC)
18.71%

5-Year Return

MLEC
94.08%
S&P 500 (^GSPC)
116.85%

Compare To: MLEC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MLEC

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    23.24M

  • Enterprise Value

    41.72M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.07

  • Price/Book (mrq)

    4.08

  • Enterprise Value/Revenue

    7.67

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -140.33%

  • Return on Assets (ttm)

    -20.16%

  • Return on Equity (ttm)

    -104.72%

  • Revenue (ttm)

    5.44M

  • Net Income Avi to Common (ttm)

    -7.64M

  • Diluted EPS (ttm)

    -0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.61M

  • Total Debt/Equity (mrq)

    387.90%

  • Levered Free Cash Flow (ttm)

    -14.9M

Research Analysis: MLEC

View More

Company Insights: MLEC

Research Reports: MLEC

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.